Tafazzin (TAZ) (Middle Region) Peptide
TAZ
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all TAZ products
- TAZ (Tafazzin (TAZ))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- LHSHFFSLGK CVPVCRGAEF FQAENEGKGV LDTGRHMPGA GKRREKGDGV
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-TAZ Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Tafazzin (TAZ) peptide
TAZ Reactivity: Human, Mouse, Rat, Dog Host: Synthetic BP, Imm
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- TAZ (Tafazzin (TAZ))
- Synonyms
- wu:fb39f12 Peptide, zgc:91803 Peptide, MGC54019 Peptide, TAZ Peptide, taz Peptide, GB11956 Peptide, Afu2g13960 Peptide, BTHS Peptide, CMD3A Peptide, EFE Peptide, EFE2 Peptide, G4.5 Peptide, LVNCX Peptide, Taz1 Peptide, 5031411C02Rik Peptide, 9130012G04Rik Peptide, AW107266 Peptide, AW552613 Peptide, tafazzin Peptide, tafazzin L homeolog Peptide, tafazzin homolog Peptide, TAZ Peptide, taz Peptide, taz.L Peptide, LOC550948 Peptide, AFUA_2G13960 Peptide, AOR_1_318014 Peptide, Tsp_06712 Peptide, Taz Peptide
- Background
-
This gene encodes a protein that is expressed at high levels in cardiac and skeletal muscle. Mutations in this gene have been associated with a number of clinical disorders including Barth syndrome, dilated cardiomyopathy (DCM), hypertrophic DCM, endocardial fibroelastosis, and left ventricular noncompaction (LVNC). Multiple transcript variants encoding different isoforms have been described. A long form and a short form of each of these isoforms is produced, the short form lacks a hydrophobic leader sequence and may exist as a cytoplasmic protein rather than being membrane-bound. Other alternatively spliced transcripts have been described but the full-length nature of all these transcripts is not known.
Alias Symbols: TAZ,EFE2,G4.5,
Protein Size: 292 - Gene ID
- 6901
- UniProt
- Q16635
-
You are here:
